Clinical Trial Update: Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children [Phase 3]

View source ↗

Summary

Phase 3 trial results assessing the safety and immune response of the MenACWY conjugate vaccine in healthy children have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• MenACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-06-09